Electrophysiological approaches to informing therapeutic interventions with deep brain stimulation.

Neuromodulation therapy comprises a range of non-destructive and adjustable methods for modulating neural activity using electrical stimulations, chemical agents, or mechanical interventions. Here, we discuss how electrophysiological brain recording and imaging at multiple scales, from cells to large-scale brain networks, contribute to defining the target location and stimulation parameters of neuromodulation, with an emphasis on deep brain stimulation (DBS).

Human Auditory-Motor Networks Show Frequency-Specific Phase-Based Coupling in Resting-State MEG.

Perception and production of music and speech rely on auditory-motor coupling, a mechanism which has been linked to temporally precise oscillatory coupling between auditory and motor regions of the human brain, particularly in the beta frequency band. Recently, brain imaging studies using magnetoencephalography (MEG) have also shown that accurate auditory temporal predictions specifically depend on phase coherence between auditory and motor cortical regions. However, it is not yet clear whether this tight oscillatory phase coupling is an intrinsic feature of the auditory-motor loop, or whether it is only elicited by task demands.

The Lifespan Evolution of Individualized Neurophysiological Traits.

Unlabelled: How do neurophysiological traits that characterize individuals evolve across the lifespan? To address this question, we analyzed brief, task-free magnetoencephalographic recordings from over 1,000 individuals aged 4-89. We found that neurophysiological activity is significantly more similar between individuals in childhood than in adulthood, though periodic patterns of brain activity remain reliable markers of individuality across all ages. The cortical regions most critical for determining individuality shift across neurodevelopment and aging, with sensorimotor cortices becoming increasingly prominent in adulthood.

Cortical effects of dopamine replacement account for clinical response variability in Parkinson's disease.

Individual variability in clinical response to dopaminergic replacement therapy (DRT) is a key barrier to efficacious treatment for patients with Parkinson's disease (PD). A better understanding of the neurobiological sources of such inter-individual differences is necessary to inform future clinical interventions and motivate translational research. One potential source of this variability is an unintended secondary activation of extra-nigrostriatal dopamine systems by DRT, particularly in the neocortex.